Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)

This study has been withdrawn prior to enrollment.
(echo contrast agents no longer allowed in CAD patients.)
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT00286559
First received: February 2, 2006
Last updated: March 24, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2008
  Estimated Primary Completion Date: No date given